• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族史与乳腺癌后第二原发乳腺癌的风险。

Family History and Risk of Second Primary Breast Cancer after Breast Carcinoma.

机构信息

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

出版信息

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):315-320. doi: 10.1158/1055-9965.EPI-17-0837. Epub 2018 Jan 16.

DOI:10.1158/1055-9965.EPI-17-0837
PMID:29339357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5835196/
Abstract

Incidence rates of breast carcinomas have increased due to widespread adoption of mammography. Very little is known about why some women with breast cancer later develop second primary breast cancers. In this population-based nested case-control study among breast cancer survivors, including 539 cases with a second primary breast cancer and 994 matched controls, we evaluated the association between first-degree family history of breast cancer and risk of developing a second primary breast cancer. First-degree family history of breast cancer was associated with an increased risk of developing a second primary breast cancer among women with a previous breast cancer [odds ratio (OR) = 1.33, 95% confidence interval (CI), 1.05-1.69] and those with two or more affected first-degree relatives had an even higher risk (OR = 1.94; 95% CI, 1.15-3.28). Those whose relative was diagnosed at less than 50 years old were more likely to develop a second primary breast cancer (OR = 1.78; 95% CI, 1.24-2.57). No difference in risks associated with number or age of affected relatives was observed by menopausal status. Results from this study suggest that first-degree family history of breast cancer may be an important risk factor for development of a second primary breast cancer among women with a previous breast cancer. Given the growing population of breast cancer survivors, a better understanding of risk factors associated with development of a second primary breast cancer is needed to further understand risk. .

摘要

由于广泛采用乳房 X 光摄影术,乳腺癌的发病率有所上升。但是,对于为什么一些患有乳腺癌的女性后来会发展出第二个原发性乳腺癌,人们知之甚少。在这项针对乳腺癌幸存者的基于人群的巢式病例对照研究中,包括 539 例第二原发性乳腺癌病例和 994 例匹配对照,我们评估了一级亲属乳腺癌家族史与发展第二原发性乳腺癌风险之间的关系。一级亲属乳腺癌家族史与先前患有乳腺癌的女性发生第二原发性乳腺癌的风险增加相关(比值比 [OR] = 1.33,95%置信区间 [CI],1.05-1.69),且有两个或更多受影响一级亲属的女性风险更高(OR = 1.94;95% CI,1.15-3.28)。那些相对被诊断为 50 岁以下的人更有可能患上第二原发性乳腺癌(OR = 1.78;95% CI,1.24-2.57)。在绝经状态下,与受影响亲属的数量或年龄相关的风险没有差异。本研究结果表明,一级亲属乳腺癌家族史可能是既往患有乳腺癌的女性发展第二原发性乳腺癌的重要危险因素。鉴于乳腺癌幸存者人数不断增加,需要更好地了解与第二原发性乳腺癌发展相关的风险因素,以进一步了解风险。

相似文献

1
Family History and Risk of Second Primary Breast Cancer after Breast Carcinoma.家族史与乳腺癌后第二原发乳腺癌的风险。
Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):315-320. doi: 10.1158/1055-9965.EPI-17-0837. Epub 2018 Jan 16.
2
The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.原位乳腺癌和家族史对后续乳腺癌事件及死亡率的影响——一项来自瑞典的基于人群的研究。
Breast Cancer Res. 2016 Oct 18;18(1):105. doi: 10.1186/s13058-016-0764-7.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
4
The genetic epidemiology of second primary breast cancer.第二原发性乳腺癌的遗传流行病学
Am J Epidemiol. 1992 Oct 15;136(8):937-48. doi: 10.1093/oxfordjournals.aje.a116566.
5
Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.基于人群的乳腺癌发病率和生存结局分析:诊断为乳腺小叶原位癌的女性。
Ann Surg Oncol. 2017 Sep;24(9):2509-2517. doi: 10.1245/s10434-017-5867-6. Epub 2017 Apr 28.
6
Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma.原位乳腺癌后的生殖和绝经因素与第二原发性乳腺癌风险
Cancer Causes Control. 2019 Jan;30(1):113-120. doi: 10.1007/s10552-018-1119-8. Epub 2018 Dec 11.
7
Breast cancer risk factors and second primary malignancies among women with breast cancer.乳腺癌女性患者的乳腺癌风险因素及第二原发性恶性肿瘤
Breast Cancer Res Treat. 2007 Oct;105(2):195-207. doi: 10.1007/s10549-006-9446-y. Epub 2006 Dec 21.
8
Risk factors for contralateral breast cancer in Chennai (Madras), India.印度钦奈(马德拉斯)对侧乳腺癌的危险因素。
Int J Epidemiol. 1998 Oct;27(5):743-50. doi: 10.1093/ije/27.5.743.
9
Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.接受乳房X光检查人群中对侧乳腺癌的风险:家族史、诊断年龄和组织学的影响。
Breast Cancer Res Treat. 2007 Oct;105(2):229-36. doi: 10.1007/s10549-006-9445-z. Epub 2006 Nov 18.
10
Risk factors for colorectal cancer following breast cancer.乳腺癌后结直肠癌的危险因素。
Breast Cancer Res Treat. 2003 May;79(2):143-7. doi: 10.1023/a:1023926401227.

引用本文的文献

1
Genetic Variants Associated with Breast Cancer Are Detected by Whole-Exome Sequencing in Vietnamese Patients.越南患者通过全外显子组测序检测出与乳腺癌相关的基因变异。
Diagnostics (Basel). 2025 Aug 28;15(17):2187. doi: 10.3390/diagnostics15172187.
2
Current trends in breast cancer genetics, risk factors, and screening strategies.乳腺癌遗传学、风险因素及筛查策略的当前趋势
J Biol Methods. 2025 Mar 13;12(2):e99010054. doi: 10.14440/jbm.2025.0079. eCollection 2025.
3
Elacestrant in the treatment landscape of ER-positive, HER2-negative, ESR1-mutated advanced breast cancer: a contemporary narrative review.艾拉司群在雌激素受体阳性、人表皮生长因子受体2阴性、雌激素受体1基因突变的晚期乳腺癌治疗格局中的应用:一篇当代叙述性综述
Ann Med Surg (Lond). 2024 Jun 19;86(8):4624-4633. doi: 10.1097/MS9.0000000000002293. eCollection 2024 Aug.
4
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.三阴性乳腺癌:关于流行病学、危险因素、信号通路、治疗及人工智能作用的简要综述
Front Mol Biosci. 2022 Jan 25;9:836417. doi: 10.3389/fmolb.2022.836417. eCollection 2022.
5
Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review.乳腺癌——流行病学、危险因素、分类、预后标志物及当前治疗策略——最新综述
Cancers (Basel). 2021 Aug 25;13(17):4287. doi: 10.3390/cancers13174287.
6
Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma .双膦酸盐的使用与乳腺导管癌女性乳腺癌风险的相关性。
Cancer Res. 2021 May 15;81(10):2799-2802. doi: 10.1158/0008-5472.CAN-20-4100. Epub 2021 Mar 24.
7
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review.原发性 DCIS 后同侧事件风险的患者特征和生活方式因素的影响:系统评价。
Breast. 2020 Apr;50:95-103. doi: 10.1016/j.breast.2020.02.006. Epub 2020 Feb 19.
8
Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014.在一个没有基于人群的乳腺 X 线筛查计划的地区,原位乳腺癌发病率呈上升趋势:来自瑞士苏黎世 2003-2014 年的结果。
J Cancer Res Clin Oncol. 2019 Mar;145(3):653-660. doi: 10.1007/s00432-018-2822-2. Epub 2018 Dec 13.
9
Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma.原位乳腺癌后的生殖和绝经因素与第二原发性乳腺癌风险
Cancer Causes Control. 2019 Jan;30(1):113-120. doi: 10.1007/s10552-018-1119-8. Epub 2018 Dec 11.

本文引用的文献

1
The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.原位乳腺癌和家族史对后续乳腺癌事件及死亡率的影响——一项来自瑞典的基于人群的研究。
Breast Cancer Res. 2016 Oct 18;18(1):105. doi: 10.1186/s13058-016-0764-7.
2
Genetic predisposition to ductal carcinoma in situ of the breast.乳腺导管原位癌的遗传易感性。
Breast Cancer Res. 2016 Feb 17;18(1):22. doi: 10.1186/s13058-016-0675-7.
3
Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study.乳腺癌多发性、左右侧发病和发病年龄对乳腺癌家族发病风险的影响:一项全国性前瞻性队列研究。
Breast Cancer Res Treat. 2014 Feb;144(1):185-92. doi: 10.1007/s10549-014-2848-3. Epub 2014 Feb 1.
4
Risk of second breast cancer according to estrogen receptor status and family history.根据雌激素受体状态和家族史评估二次乳腺癌风险。
Breast Cancer Res Treat. 2011 May;127(1):233-41. doi: 10.1007/s10549-010-1137-z. Epub 2010 Sep 29.
5
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.美国国立卫生研究院科学会议声明:导管原位癌的诊断和治疗,2009 年 9 月 22 日至 24 日。
J Natl Cancer Inst. 2010 Feb 3;102(3):161-9. doi: 10.1093/jnci/djp485. Epub 2010 Jan 13.
6
Clinical dilemma of ductal carcinoma in situ.导管原位癌的临床困境
J Clin Oncol. 2009 Nov 10;27(32):5303-5. doi: 10.1200/JCO.2009.24.1489. Epub 2009 Oct 13.
7
Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004.1995年至2004年美国按组织学亚型和种族/族裔划分的乳腺癌发病率变化
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2773-80. doi: 10.1158/1055-9965.EPI-07-0546.
8
Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.基于人群的登记研究中,原位乳腺癌后发生第二原发性恶性肿瘤的风险增加。
Br J Cancer. 2006 Aug 7;95(3):393-7. doi: 10.1038/sj.bjc.6603231. Epub 2006 Jun 27.
9
Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.1980年至2001年按组织学类型划分的原位乳腺癌年龄别发病率
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1008-11. doi: 10.1158/1055-9965.EPI-04-0849.
10
Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.原位和浸润性乳腺癌的不同发病模式及其可能的病因学意义。
Breast Cancer Res Treat. 2004 Nov;88(2):149-59. doi: 10.1007/s10549-004-1483-9.